Pacira Pharmaceuticals, Inc. (PCRX)

[surf1944]

6:30AM Pacira Pharma announces U.S. FDA approval of EXPAREL for postsurgical pain management (PCRX) 10.18 : Co announces that the FDA has approved EXPAREL 1.3% for administration into the surgical site to produce postsurgical analgesia. In a pivotal hemorrhoidectomy trial of EXPAREL compared to placebo, where all patients with inadequate pain control received opioids for rescue pain relief, EXPAREL demonstrated significant reductions in cumulative pain scores with an attendant decrease in opioid consumption for up to 72 hours.